# Polymyxin B

NDC: 55150-234
Generic name: Polymyxin B
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, OPHTHALMIC
Marketing started: 20160404

FDA application: ANDA206589

## Active ingredients

- POLYMYXIN B SULFATE: 500000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-234"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-234
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a974c557-e88f-451b-a1bd-d2c656be226e